Harvard Business Review

JUNE 25, 2013

The most recent data comes from a 2013 study by the Ponemon Institute and Symantec of 277 companies that experienced losses or thefts of protected personal data. But in heavily regulated industries such as health care, financial services, pharmaceuticals, transportation, and communications, the cost is substantially higher.

Cost 8

Cost Software Pharmaceuticals Health Care 8

Harvard Business Review

OCTOBER 24, 2013

noted the irony that because of sequester cuts, NIH funding was reduced for the research that resulted in Yale’s James Rothman sharing in the 2013 Nobel Prize for Medicine. Cuts to 2013 budget : $285 Million or 5%. Cuts to 2013 budget: $11.08 Cuts to 2013 budget : $209 Million or 5%. Congresswoman Zoe Lofgren (D-Calif.)

Health Care 8

Health Care Budgeting Pharmaceuticals Review 8

Harvard Business Review

OCTOBER 23, 2012

The contest opens on October 25 at robocall.challenge.gov , and will run through January 17, 2013. Coca-Cola recently teamed up with French pharmaceutical company Sanofi to create a line of drinks to “aid health and beauty.” EXCUSEZ-MOI, MADAME, BUT HOW DO YOU MANAGE TO LOOK SO CHIC? Coke Adds Life to French Beauty Industry (Wired).

Telemarketing 8

Telemarketing Pharmaceuticals Fashion Letter 8

Harvard Business Review

DECEMBER 27, 2013

October 2013) The Dark Side of Generic Drugs Dirty Medicine Fortune Generic drugs can be inexpensive and effective alternatives to their branded counterparts. Sure, the company was eventually both punished and sold (it’s now one of the fastest-growing pharmaceutical businesses in the U.S.). And we all know what happened next.

Armstrong 8

Armstrong Long-term Short-term CEO 8

Harvard Business Review

NOVEMBER 30, 2017

A few outlier industries (notably pharmaceuticals, medical devices, and computers) prop up the sector’s aggregate performance; most others have experienced flat growth or outright declines in real GDP over the past two decades.

Supply Chain 8

Supply Chain McKinsey Incentives Bottom-up 8

Harvard Business Review

JULY 17, 2014

When Raja Rajamannar became CMO of MasterCard Worldwide in 2013, he moved quickly to transform how the credit card giant measures marketing. His artillery: Advanced Big Data analytics. MasterCard had always been a data-driven organization. But the real power and full potential of data was not being fully realized by marketing.

Finance 13

Finance Marketing P&L ROI 13

Harvard Business Review

JANUARY 13, 2014

But for 2013 he was only about 15 percent on target. But his 2013 forecasts were certainly within the realm of the possible; they just failed to materialize this year. Companies in the pharmaceutical industry – particularly in the U.S. – Most years he is about 50 percent correct. Gold did not reach $1,900 an ounce.

Uncertainty 8

Uncertainty Pharmaceuticals Industry Marketing 8

Harvard Business Review

MAY 26, 2014

billion in 2013, up 39% from 2012. Entities like Optum Labs are bringing together physicians, pharmaceuticals companies, hospitals, ACOs, and researchers to identify predictive analytic algorithms than can anticipate when patients are likely to get ill — so that we can intervene and improve outcomes.

Health Care 8

Health Care Venture Funding Entrepreneur Pharmaceuticals 8

Harvard Business Review

MARCH 31, 2016

For example, between 1995 and 2013, the top five pharmaceutical companies shed more than 55% of their salespeople in the US. This knowledge gap will create a need for salespeople to help buyers navigate unknown waters, even in today’s environment. But in that same time period, new companies added salespeople.

B2B 8

B2B B2C Uncertainty Self-aware 8

Harvard Business Review

APRIL 3, 2017

The company was an eager user of my “cascading choices” framework for strategy that I have used for decades and written about extensively, most prominently in the 2013 book I wrote, with friend and colleague A.G. Lafley, called Playing to Win.

First-mover Advantage 15

First-mover Advantage Retail Strategy Pharmaceuticals 15

Harvard Business Review

AUGUST 23, 2012

These hurdles aren't unique to financial services — insurance, pharmaceuticals, health care and government all face regulation, to name a few examples. By the end of 2013, Gartner research estimates half of all companies will have to produce social media records for e-discovery. The risks and penalties are real.

Compliance 15

Compliance Media Compliance Officer Policies 15

Harvard Business Review

MARCH 16, 2015

Please note that titles used here reflect the positions the individuals held in 2013, when we conducted the interviews for a separate article ). Ken Frazier of the pharmaceutical firm Merck, put it this way: “The biggest challenges that we faced in our organization was that healthcare in general was undergoing huge, huge pivotal change.

CEO 8

CEO Stephenson Pharmaceuticals Globalization 8

Harvard Business Review

FEBRUARY 14, 2014

Because of Kendall Square’s concentration of talent, and its infrastructure, Novartis, the giant Swiss pharmaceutical company, moved nearly its entire research center here from Switzerland. Not only can natural gas be used as a feedstock for chemicals, fertilizers, pesticides, paints, plastics, and cosmetics, in 2013 the Cummins Corp.

Chemicals 8

Chemicals Pharmaceuticals Energy Creativity 8

Harvard Business Review

OCTOBER 21, 2013

I found myself reflecting on this recently while speaking with two business leaders in one of the world’s great pharmaceutical companies. This post is part of a series of perspectives leading up to the fifth annual Global Drucker Forum in November 2013 in Vienna, Austria. It’s a tough challenge. Leadership Managing uncertainty'

Drucker 8

Drucker Diversity Pharmaceuticals Uncertainty 8

Harvard Business Review

SEPTEMBER 22, 2015

As the ire over high prescription drug prices in the United States escalates , it’s easy to blame pharmaceutical companies. But pharmaceutical companies aren’t to blame. rose by 8 times the general inflation rate in 2013. There are compelling reasons, however, to consider doing so for pharmaceuticals.

Pharmaceuticals 8

Pharmaceuticals Price Budgeting Insurance 8

Harvard Business Review

NOVEMBER 4, 2014

Take Sovaldi, launched by Gilead Sciences in late 2013 as a treatment for hepatitis C virus (HCV) infection and recently superseded by Gilead’s newest drug, Harvoni. To illustrate the problem, let’s start with an example from October 2013, when Express Scripts decided to exclude 46 drugs from its formulary.

Cost 8

Cost Committee Insurance Health Care 8

Harvard Business Review

NOVEMBER 4, 2014

Take Sovaldi, launched by Gilead Sciences in late 2013 as a treatment for hepatitis C virus (HCV) infection and recently superseded by Gilead’s newest drug, Harvoni. To illustrate the problem, let’s start with an example from October 2013, when Express Scripts decided to exclude 46 drugs from its formulary.

Cost 8

Cost Committee Insurance Health Care 8

Harvard Business Review

JULY 30, 2015

This continues a trend The Association of National Advertisers first reported in 2013. A new research report from the Society of Digital Agencies finds that in the past year there has been a dramatic spike in the number of companies who no longer work with outside marketing agencies — 27 percent, up from 13 percent in the previous year.

Marketing 8

Marketing Advertising Trends Brand 8

Harvard Business Review

FEBRUARY 6, 2014

Consider the CEO succession process at pharmaceutical giant GlaxoSmithKline beginning in 2004 when chief executive Jean-Pierre Garnier said he would be exiting in three years. Or consider managed-health care provider Humana’s decision in 2013 to recruit an outsider as its next chief executive.

CEO 8

CEO Bottom-up Strategic Fit Pharmaceuticals 8

Harvard Business Review

AUGUST 17, 2015

It could be an ideal location for healthcare organizations, but also for those in applied sciences, biotechnology, and pharmaceuticals. pharmaceutical company could be a great asset in the future. In 2013 in U.S. We know two things about biotech in Cuba. One is that the quality of applied science seems to be first rate.

Biotechnology 8

Biotechnology Tourism Human Capital Pharmaceuticals 8

Harvard Business Review

MAY 5, 2016

However, oil prices have dropped more than 60% since the interim nuclear deal in November 2013. And Danish pharmaceutical company Novo Nordisk is building on its Iran presence by doubling local staff to nearly 300 and investing $76 million in a new factory.

Tourism 8

Tourism Banking Due Diligence Hotels 8

Harvard Business Review

FEBRUARY 2, 2015

industries: 35 advanced manufacturing industries such as automotive and aerospace manufacturing, pharmaceuticals and semiconductors; three energy industries including electric power generation; and 12 service industries, from software design to telecommunications. average (20%) of highly intensive STEM occupations.

Industry 8

Industry McKinsey Engineering Innovation 8

Harvard Business Review

FEBRUARY 11, 2016

McKesson, the US-based pharmaceutical and health-care giant, benefits from external expertise as a strategic extension of its resources in areas such as business strategy and logistics support. Studies of the global agile-talent community vary in their estimates of the size of the population.

Agility 8

Agility Organization Resources Fixed Costs 8

Harvard Business Review

MAY 15, 2013

Beginning May 1, 2013, I facilitated a discussion around this question on LinkedIn. a fast-moving consumer products division vs. a pharmaceuticals division of a diversified firm). Nor can we develop good approaches to analyzing, preserving and transforming cultures. finance vs. marketing) and units (e.g.

Incentives 8

Incentives Definition Pharmaceuticals System 8

Harvard Business Review

NOVEMBER 25, 2015

One 2013 study illustrates this well. The Chief Talent Officer at UCB Pharmaceuticals told us how he recently started inviting patients to executive meetings, so the people making decisions can see how their work makes a difference. Insight Center. How to Be a Company That Employees Love. Sponsored by Citrix GoToMeeting.

Motivation 8

Motivation Company Airlines Learning-by-Doing 8

Harvard Business Review

OCTOBER 27, 2014

doubled from 20% to 40% between July and December 2013, and has stayed at that level since. I studied large-scale change and innovation efforts in 56 randomly selected companies in the high-tech, retail, pharmaceutical, banking, automotive, insurance, energy, non-profit, and health care industries.

Middle Management 13

Middle Management Six Sigma Taylorism Taylor 13

Harvard Business Review

OCTOBER 11, 2013

By 2013, we had honored Jack Dorsey of Twitter, Garrett Camp of Uber, famed choreographer Twyla Tharp, and Gangnam style pop artist Psy. Celine Schillinger sought to change the leadership landscape of Sanofi, a major pharmaceutical company. If you say we should, let’s do it.

Innovation 11

Innovation Christensen Decisionmaking CTO 11

Harvard Business Review

MARCH 6, 2014

Indeed, should this have not crossed your mind, the PLoS authors tie their findings to past behavior by the tobacco and pharmaceutical industries. The researchers looked at systematic reviews conducted between 2006 and 2013. But this period saw a significant change in the kind of research done on sugar and weight gain.

Peer Review 8

Peer Review Review Industry Wilde 8

Great Leadership By Dan

FEBRUARY 7, 2014

years), while the pharmaceutical (5.7 In the Americas, the expectation was slightly longer (7.9 years), while in Asia-Pacific, it was shorter (5.9 Length of service also differed by industry. Professional services tend to retain senior executives the longest (8.1 years) and consumer products (6.1

Execution 283

Execution Company Press Release Survey 283

Harvard Business Review

JUNE 24, 2015

By taking an adaptive approach that focuses on monitoring the environment, strategic experimentation, and organizational flexibility, Tata Consultancy Services has grown from $155 million in revenue in 1996 to $1 billion in 2003 and more than $13 billion in 2013 to become the second-largest pure IT services company in the world.

Strategy 8

Strategy Competitive Advantage Environment Execution 8

Harvard Business Review

FEBRUARY 24, 2017

While roughly 20% of lawmakers owned stock in 2001, that number had more than doubled by 2013. Congresspeople in both political parties have substantial holdings in firms their legislative actions affect — and this number has grown substantially in recent years. Not only did his wife invest between $610,000 and $1.5

Conflict of Interest 8

Conflict of Interest Committee Collins Politics 8

Harvard Business Review

DECEMBER 21, 2015

Yet with all its foreign cash, Apple borrowed over $62 billion in 2013–2015 to do buybacks rather than repatriate its profits and pay U.S. Which brings us back to Pfizer, the pharmaceutical drug company that has provoked the new round of patriotic denunciations of corporate tax flight. Pfizer’s CEO, Ian C.

Hedge 8

Hedge Proposal Pharmaceuticals Price 8